These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25031389)

  • 21. Perspective of cytokine regulation for periodontal treatment: fibroblast biology.
    Takashiba S; Naruishi K; Murayama Y
    J Periodontol; 2003 Jan; 74(1):103-10. PubMed ID: 12593604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-1 as a target in inflammation.
    Ito Y; Kaneko N; Iwasaki T; Morikawa S; Kaneko K; Masumoto J
    Endocr Metab Immune Disord Drug Targets; 2015; 15(3):206-11. PubMed ID: 26333726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-6: An Important Mediator of Allograft Injury.
    Jordan SC; Ammerman N; Choi J; Kumar S; Huang E; Toyoda M; Kim I; Wu G; Vo A
    Transplantation; 2020 Dec; 104(12):2497-2506. PubMed ID: 32235253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer.
    Leanderson T; Liberg D; Ivars F
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):97-104. PubMed ID: 25772177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel investigational drugs targeting IL-6 signaling for the treatment of depression.
    Fonseka TM; McIntyre RS; Soczynska JK; Kennedy SH
    Expert Opin Investig Drugs; 2015 Apr; 24(4):459-75. PubMed ID: 25585966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-6 trans-signalling in chronic inflammation and cancer.
    Scheller J; Ohnesorge N; Rose-John S
    Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
    Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triclosan inhibition of acute and chronic inflammatory gene pathways.
    Barros SP; Wirojchanasak S; Barrow DA; Panagakos FS; Devizio W; Offenbacher S
    J Clin Periodontol; 2010 May; 37(5):412-8. PubMed ID: 20507366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-6 blockade in ocular inflammatory diseases.
    Mesquida M; Leszczynska A; Llorenç V; Adán A
    Clin Exp Immunol; 2014 Jun; 176(3):301-9. PubMed ID: 24528300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 signaling pathway in targeted therapy for cancer.
    Guo Y; Xu F; Lu T; Duan Z; Zhang Z
    Cancer Treat Rev; 2012 Nov; 38(7):904-10. PubMed ID: 22651903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor and anti-tumor necrosis factor therapies.
    Keystone EC; Ware CF
    J Rheumatol Suppl; 2010 May; 85():27-39. PubMed ID: 20436163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
    Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
    J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The IL-23 to IL-17 cascade inflammation-related cancers.
    Wang K; Karin M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S87-90. PubMed ID: 26457610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoechinulin A suppresses amyloid-β oligomer-induced microglia activation and thereby protects PC-12 cells from inflammation-mediated toxicity.
    Dewapriya P; Li YX; Himaya SW; Pangestuti R; Kim SK
    Neurotoxicology; 2013 Mar; 35():30-40. PubMed ID: 23261590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response.
    Murray PJ
    Curr Opin Pharmacol; 2006 Aug; 6(4):379-86. PubMed ID: 16713356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The IL-6 feed-forward loop: a driver of tumorigenesis.
    Chang Q; Daly L; Bromberg J
    Semin Immunol; 2014 Feb; 26(1):48-53. PubMed ID: 24613573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 6: from bench to bedside.
    Nishimoto N; Kishimoto T
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):619-26. PubMed ID: 17075601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-6: an angiogenic target in solid tumours.
    Middleton K; Jones J; Lwin Z; Coward JI
    Crit Rev Oncol Hematol; 2014 Jan; 89(1):129-39. PubMed ID: 24029605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term exposure to IL-1beta enhances Toll-IL-1 receptor-mediated inflammatory signaling in murine airway hyperresponsiveness.
    Zhang Y; Xu CB; Cardell LO
    Eur Cytokine Netw; 2009 Sep; 20(3):148-56. PubMed ID: 19825525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.